- Home
- MDXG vs BLND Comparison
MDXG vs BLND Comparison
Compare MDXG & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BLND
- Stock Information
- Founded
- MDXG 2006
- BLND 2012
- Country
- MDXG United States
- BLND United States
- Employees
- MDXG N/A
- BLND N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BLND EDP Services
- Sector
- MDXG Health Care
- BLND Technology
- Exchange
- MDXG Nasdaq
- BLND Nasdaq
- Market Cap
- MDXG 1.0B
- BLND 946.2M
- IPO Year
- MDXG N/A
- BLND 2021
- Fundamental
- Price
- MDXG $6.43
- BLND $3.67
- Analyst Decision
- MDXG Strong Buy
- BLND Buy
- Analyst Count
- MDXG 2
- BLND 7
- Target Price
- MDXG $12.50
- BLND $4.93
- AVG Volume (30 Days)
- MDXG 852.6K
- BLND 2.7M
- Earning Date
- MDXG 04-30-2025
- BLND 05-08-2025
- Dividend Yield
- MDXG N/A
- BLND N/A
- EPS Growth
- MDXG N/A
- BLND N/A
- EPS
- MDXG 0.27
- BLND N/A
- Revenue
- MDXG $352,375,000.00
- BLND $164,949,000.00
- Revenue This Year
- MDXG $9.44
- BLND N/A
- Revenue Next Year
- MDXG $11.54
- BLND $26.10
- P/E Ratio
- MDXG $23.82
- BLND N/A
- Revenue Growth
- MDXG 5.34
- BLND 15.07
- 52 Week Low
- MDXG $5.47
- BLND $2.08
- 52 Week High
- MDXG $10.14
- BLND $5.53
- Technical
- Relative Strength Index (RSI)
- MDXG 38.95
- BLND 62.20
- Support Level
- MDXG $6.46
- BLND $3.39
- Resistance Level
- MDXG $6.90
- BLND $3.75
- Average True Range (ATR)
- MDXG 0.23
- BLND 0.14
- MACD
- MDXG -0.05
- BLND 0.00
- Stochastic Oscillator
- MDXG 1.02
- BLND 77.78
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.